ALNY logo

Alnylam Pharmaceuticals (ALNY) Total assets

annual total assets:

$4.24B+$410.10M(+10.71%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual total assets is $4.24 billion, with the most recent change of +$410.10 million (+10.71%) on December 31, 2024.
  • During the last 3 years, ALNY annual total assets has risen by +$596.68 million (+16.38%).
  • ALNY annual total assets is now at all-time high.

Performance

ALNY Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

quarterly total assets:

$4.21B-$26.17M(-0.62%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly total assets is $4.21 billion, with the most recent change of -$26.17 million (-0.62%) on March 31, 2025.
  • Over the past year, ALNY quarterly total assets has increased by +$389.43 million (+10.18%).
  • ALNY quarterly total assets is now -0.62% below its all-time high of $4.24 billion, reached on December 31, 2024.

Performance

ALNY quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

ALNY Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.7%+10.2%
3 y3 years+16.4%+22.7%
5 y5 years+77.0%+84.8%

ALNY Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+19.6%-0.6%+26.5%
5 y5-yearat high+77.0%-0.6%+84.8%
alltimeall timeat high>+9999.0%-0.6%>+9999.0%

ALNY Total assets History

DateAnnualQuarterly
Mar 2025
-
$4.21B(-0.6%)
Dec 2024
$4.24B(+10.7%)
$4.24B(+0.8%)
Sep 2024
-
$4.21B(+4.9%)
Jun 2024
-
$4.01B(+4.8%)
Mar 2024
-
$3.82B(-0.1%)
Dec 2023
$3.83B(+8.0%)
$3.83B(-0.2%)
Sep 2023
-
$3.84B(+12.8%)
Jun 2023
-
$3.40B(+0.3%)
Mar 2023
-
$3.39B(-4.4%)
Dec 2022
$3.55B(-2.7%)
$3.55B(+0.3%)
Sep 2022
-
$3.54B(+6.2%)
Jun 2022
-
$3.33B(-3.0%)
Mar 2022
-
$3.43B(-5.8%)
Dec 2021
$3.64B(+6.9%)
$3.64B(+4.9%)
Sep 2021
-
$3.47B(-1.1%)
Jun 2021
-
$3.51B(+7.8%)
Mar 2021
-
$3.26B(-4.5%)
Dec 2020
$3.41B(+42.2%)
$3.41B(+3.0%)
Sep 2020
-
$3.31B(-2.0%)
Jun 2020
-
$3.37B(+48.0%)
Mar 2020
-
$2.28B(-4.8%)
Dec 2019
$2.40B(+52.1%)
$2.40B(-5.8%)
Sep 2019
-
$2.54B(-6.4%)
Jun 2019
-
$2.72B(+34.9%)
Mar 2019
-
$2.01B(+27.9%)
Dec 2018
$1.57B(-21.1%)
$1.57B(-6.0%)
Sep 2018
-
$1.68B(-6.4%)
Jun 2018
-
$1.79B(-7.0%)
Mar 2018
-
$1.92B(-3.6%)
Dec 2017
$1.99B(+58.0%)
$1.99B(+46.9%)
Sep 2017
-
$1.36B(-5.3%)
Jun 2017
-
$1.43B(+26.5%)
Mar 2017
-
$1.13B(-10.2%)
Dec 2016
$1.26B(-8.9%)
$1.26B(-3.8%)
Sep 2016
-
$1.31B(-5.0%)
Jun 2016
-
$1.38B(+5.0%)
Mar 2016
-
$1.32B(-5.0%)
Dec 2015
$1.39B(+28.4%)
$1.39B(-3.5%)
Sep 2015
-
$1.44B(-6.2%)
Jun 2015
-
$1.53B(-6.0%)
Mar 2015
-
$1.63B(+50.9%)
Dec 2014
$1.08B
$1.08B(+9.5%)
Sep 2014
-
$986.36M(-4.5%)
DateAnnualQuarterly
Jun 2014
-
$1.03B(-4.4%)
Mar 2014
-
$1.08B(+156.9%)
Dec 2013
$420.53M(+46.3%)
$420.53M(-6.0%)
Sep 2013
-
$447.50M(-3.3%)
Jun 2013
-
$462.56M(-1.9%)
Mar 2013
-
$471.58M(+64.0%)
Dec 2012
$287.52M(+2.0%)
$287.52M(-10.8%)
Sep 2012
-
$322.35M(+1.2%)
Jun 2012
-
$318.48M(-6.4%)
Mar 2012
-
$340.30M(+20.7%)
Dec 2011
$281.92M(-28.3%)
$281.92M(-9.1%)
Sep 2011
-
$310.22M(-9.0%)
Jun 2011
-
$340.83M(-7.6%)
Mar 2011
-
$369.05M(-6.2%)
Dec 2010
$393.26M(-18.3%)
$393.26M(-4.7%)
Sep 2010
-
$412.61M(-6.3%)
Jun 2010
-
$440.18M(-5.0%)
Mar 2010
-
$463.41M(-3.7%)
Dec 2009
$481.38M(-13.2%)
$481.38M(-2.9%)
Sep 2009
-
$495.67M(-4.4%)
Jun 2009
-
$518.65M(-6.5%)
Mar 2009
-
$554.53M(-0.0%)
Dec 2008
$554.68M(+12.3%)
$554.68M(-4.4%)
Sep 2008
-
$580.18M(+0.0%)
Jun 2008
-
$580.05M(+19.3%)
Mar 2008
-
$486.26M(-1.5%)
Dec 2007
$493.79M(+105.7%)
$493.79M(-2.2%)
Sep 2007
-
$505.09M(+129.9%)
Jun 2007
-
$219.66M(-3.4%)
Mar 2007
-
$227.34M(-5.3%)
Dec 2006
$240.01M(+144.0%)
$240.01M(+66.1%)
Sep 2006
-
$144.53M(-1.8%)
Jun 2006
-
$147.11M(-4.3%)
Mar 2006
-
$153.69M(+56.3%)
Dec 2005
$98.35M(+48.8%)
$98.35M(+127.4%)
Sep 2005
-
$43.25M(-15.0%)
Jun 2005
-
$50.86M(-13.9%)
Mar 2005
-
$59.07M(-10.6%)
Dec 2004
$66.11M(+87.9%)
$66.11M(+5.7%)
Sep 2004
-
$62.55M(-8.7%)
Jun 2004
-
$68.47M(+74.1%)
Mar 2004
-
$39.34M(+11.8%)
Dec 2003
$35.18M(+118.4%)
$35.18M
Dec 2002
$16.11M
-

FAQ

  • What is Alnylam Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual total assets year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly total assets year-on-year change?

What is Alnylam Pharmaceuticals annual total assets?

The current annual total assets of ALNY is $4.24B

What is the all time high annual total assets for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual total assets is $4.24B

What is Alnylam Pharmaceuticals annual total assets year-on-year change?

Over the past year, ALNY annual total assets has changed by +$410.10M (+10.71%)

What is Alnylam Pharmaceuticals quarterly total assets?

The current quarterly total assets of ALNY is $4.21B

What is the all time high quarterly total assets for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly total assets is $4.24B

What is Alnylam Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, ALNY quarterly total assets has changed by +$389.43M (+10.18%)
On this page